The 2026 Ellis Fischel Clinical Cancer Symposium brings together healthcare professionals, educators, and researchers to share the latest advancements in cancer prevention, diagnosis, treatment, and survivorship. Presentations will highlight evidence-based practices and practical tools for physicians, nurses, therapists, and other healthcare professionals. This year’s symposium features topics including artificial intelligence, Alpha-Gal syndrome, GLP-1 therapies, pharmacy, and specialty-specific areas of care. The conference fosters interdisciplinary collaboration, enhances clinical knowledge and skills, and supports the delivery of high-quality, evidence-based care. Ultimately, it is designed to strengthen clinical practice and improve comprehensive cancer care for patients and their families.
